Comparison of the Efficacy of One Level and Tow Level of Bilateral Thoracic Erector Spinae Plane Block Combined With General Anesthesia in Laparoscopic Bariatric Surgery for Obese Patients: Randomized Controlled Trial

Launched by KASR EL AINI HOSPITAL · Feb 5, 2025

Keywords

ClinConnect Summary

This clinical trial is looking at two different methods of providing pain relief during and after surgery for obese patients undergoing laparoscopic bariatric surgery, which includes procedures like sleeve gastrectomy and Roux-en-Y gastric bypass. Specifically, it compares a single injection (one-level) versus two injections (two-level) of a type of nerve block called the thoracic erector spinae plane block. The goal is to see which method works better in managing pain during and after the surgery.

To be eligible for this study, patients should be between 18 and 60 years old, have a body mass index (BMI) of 35 or higher, and be classified as having a moderate health status by the American Society of Anesthesiologists. Patients who refuse the nerve block or have certain medical conditions, like neurological disorders or bleeding problems, cannot participate. Those who join can expect to receive either the one-level or two-level nerve block before their surgery and will be monitored for pain relief effectiveness during their recovery. This trial is currently recruiting participants and is important for improving pain management techniques in bariatric surgery.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • • Patient age ranges 18 to 60 years old
• • Obese patients ; Body mass index(BMI) ≥ 35 - 50 kg/m2
• • American Society of Anesthesiologists (ASA) physical status classes II to III
• • Patients scheduled for laparoscopic bariatric surgery i.e. sleeve gastrectomy and/or Roux-en-Y gastric bypass (RYGB) surgeries
• Exclusion Criteria:
• • • Refusal of regional block
• • Patients with neurological, psychological disorders or those lacking cooperation
• • Patients scheduled for concomitant laparoscopic cholecystectomy or paraumbilical hernia repair or those with history of previous bariatric surgery or obstructive sleep apnea
• • Patients with anatomic abnormalities at site of injection, skin lesions or wounds at site of proposed needle insertion.
• • Patients with bleeding disorders defined as (INR \>1.4) and/ or (platelet count \<100,000/µL)
• • Patients with hepatic disease e.g. liver cell failure or hepatic malignancy or hepatic enlargement.
• • Patients who are allergic to amide local anesthetics.